Gabapentin for presumed neuropathic ocular pain.
Chronic ocular pain
Chronic pain
Gabapentin
Neuropathic ocular pain
Neuropathic pain
Ocular pain
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
09
09
2018
revised:
08
07
2020
accepted:
15
07
2020
entrez:
8
8
2020
pubmed:
8
8
2020
medline:
8
8
2020
Statut:
epublish
Résumé
To report a case of chronic neuropathic ocular pain in a patient without visual complaints. A 37-year-old male with a history of bilateral laser-assisted in situ keratomileusis (LASIK) presented with pain symptoms of 8 months duration in the left eye. The prior LASIK surgery was complicated by corneal ectasia in the left eye requiring penetrating keratoplasty and subsequent placement of a glaucoma drainage implant for uncontrolled, elevated intraocular pressure. The patient was evaluated with a complete clinical examination, including Goldmann applanation tonometry, dilated fundus examination, fluorescein angiography, optical coherence tomography, and magnetic resonance imaging. After 3 weeks of treatment with gabapentin 300 mg BID, the patient reported complete resolution of the ocular pain. The pathophysiology of neuropathic ocular pain remains poorly understood. Clinical evaluation often reveals minimal ophthalmic exam findings, leading to an underdiagnosis of the condition by ophthalmologists. Gabapentin may be an underutilized medication in the treatment of chronic ocular pain.
Identifiants
pubmed: 32760852
doi: 10.1016/j.ajoc.2020.100836
pii: S2451-9936(18)30395-5
pii: 100836
pmc: PMC7390772
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100836Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Transl Behav Med. 2012 Mar;2(1):6-8
pubmed: 24073092
Ophthalmology. 2001 Jul;108(7):1230-5
pubmed: 11425680
J Optom. 2017 Jan - Mar;10(1):5-13
pubmed: 27431455
Mol Pain. 2017 Jan-Dec;13:1744806917729306
pubmed: 28814146
Curr Neurol Neurosci Rep. 2011 Apr;11(2):156-63
pubmed: 21128023
Lancet. 2011 Jun 25;377(9784):2226-35
pubmed: 21704872
Biol Psychiatry. 2007 Dec 1;62(11):1281-7
pubmed: 17570347
Continuum (Minneap Minn). 2015 Aug;21(4 Headache):1109-17
pubmed: 26252594
Surv Ophthalmol. 2013 Nov-Dec;58(6):529-35
pubmed: 24160728
Pain Med. 2008 Oct;9(7):803-12
pubmed: 18346058
Am Fam Physician. 2016 Aug 1;94(3):227-34
pubmed: 27479625
Ocul Surf. 2019 Jul;17(3):532-539
pubmed: 30685437
Ocul Surf. 2018 Jan;16(1):31-44
pubmed: 29031645
Eur J Ophthalmol. 2012;22 Suppl 7:S106-13
pubmed: 22577038
N Engl J Med. 2005 Mar 31;352(13):1324-34
pubmed: 15800228
Pain Med. 2008 Apr;9(3):377-8
pubmed: 18366517
Cochrane Database Syst Rev. 2017 Jun 09;6:CD007938
pubmed: 28597471
Am Fam Physician. 2013 Oct 15;88(8):515-9
pubmed: 24364572
Am J Med. 2009 Oct;122(10 Suppl):S22-32
pubmed: 19801049
Acta Neurol Belg. 2019 May 27;:
pubmed: 31134508
Mayo Clin Proc. 2015 Apr;90(4):532-45
pubmed: 25841257
J Cataract Refract Surg. 2011 Feb;37(2):364-9
pubmed: 21241922
Cornea. 2015 Dec;34(12):1545-50
pubmed: 26426334
Br J Anaesth. 2013 Jul;111(1):13-8
pubmed: 23794640
J Refract Surg. 2011 Aug;27(8):613-7
pubmed: 21366172
Ophthalmology. 2016 Jul;123(7):1458-68
pubmed: 27089999
Br J Ophthalmol. 2016 Jan;100(1):128-34
pubmed: 25943558
Ophthalmology. 2017 Nov;124(11S):S34-S47
pubmed: 29055360